This site is intended for health professionals only

Saturday 20 April 2019
Share |

Topic: antimicrobial resistance

September 27, 2018

An award winning hospital team dedicated to tackling antimicrobial resistance talk about their efforts to tackle this issue and why staff engagement is essential to running a successful programme
 
Hala Kandil, microbiology consultant and antimicrobial resistance (AMR) lead, and Tejal Vaghela, lead antimicrobial pharmacist work together at West Hertfordshire Hospitals NHS Trust in the UK to help tackle antimicrobial resistance.
 

August 24, 2018

Kathy Oxtoby looks at the effects of antimicrobial resistance across Europe will be if it goes unchecked and investigates what should be done to tackle it
 
It may be a natural phenomenon, but antimicrobial resistance (AMR) has become a global health crisis of similar importance to infectious-disease pandemics, according to the World Health Organization (WHO).
 

February 9, 2017
Based on Philips’ Minicare I-20 handheld diagnostics platform, the Minicare HNL assay is recognised for its potential to provide physicians with 10-minute confirmation of bacterial infection, helping to ensure that antibiotics are only prescribed to patients who need them

Royal Philips, a leader in HealthTech, and Diagnostics Development, a P&M Venge company spin-off from Uppsala University (Sweden), have demonstrated a proof-of-concept for the rapid and reliable detection of bacterial infection.

December 7, 2015
EUCAST’s unheralded, but vital work, is helping to ensure responsible use by defining common standards for antimicrobial resistance globally
September 3, 2015
Study group calls on pharma and medical device industry to work more closely with antibacterial and anti-biofilm researchers

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organisation that explores the risks and best practices in infectious disease – advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms, which contribute to antimicrobial resistance.
 

July 9, 2015
Zevtera® (Ceftobiprole medocaril): the latest generation Cephalosporin with broad-spectrum of activity launches in the UK

Basilea Pharmaceutica AG announces the UK launch of its broad-spectrum Cephalosporin Zevtera® (Ceftobiprole medocaril) for the first-line treatment of serious bacterial pneumonia. Zevtera® is the only antibiotic approved as a monotherapy in the UK for the treatment of community-acquired (CAP) and hospital-acquired (nosocomial) pneumonia (HAP) (excluding ventilator-associated pneumonia (VAP)), that is effective against Methicillin-resistant Staphylococcus aureus (MRSA) and gram-negative pathogens such as strains of Pseudomonas aeruginosa and Enterobacteriaceae.

March 19, 2015
The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) has been joined by the World Health Organisation (WHO) to launch the 7th annual ‘International Day for Fighting Infection’ (24 April 2015). This year’s event sees the European society exploring vaccines as a possible solution in the global, cross-border fight against antimicrobial resistance.

The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) has been joined by the World Health Organisation (WHO) to launch the 7th annual ‘International Day for Fighting Infection’ (24 April 2015).  This year’s event sees the European society exploring vaccines as a possible solution in the global, cross-border fight against antimicrobial resistance.